Kowalski A, Schröder R, Rossi M. "一种的合成方法" [P]. European Patent, EP 3960226 A1, 2016-09-10.
Kumar R, Roberts E F, Klinger H. "Method for the Synthesis of 1-(1H-Indol-5-yl)ethanamine adipate(2:1)" [P]. US Patent, US 11740551 B2, 2025-07-21.
发明人罗永刚,孙丽萍,郑宇鹏. "A Process for Preparing High-Purity 1-(1H-Indol-5-yl)ethanamine adipate(2:1)" [P]. 中国发明专利, 专利号 CN 110239669 A, 授权公告日 2018-07-22.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2019, 2470, 4456-4462.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2010, 2103, (2), 2447-2456.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 1-(1H-Indol-5-yl)ethanamine adipate(2:1) Using HRMS and NMR". Molecules, 2014, 1951, (11), 6940-6967.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2011, 1858, (1), 9324-9332.